Tissue Regenix Group (LSE:TRX) Ending Cash Position : £3.67 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Ending Cash Position?

Tissue Regenix Group's Ending Cash Position for the quarter that ended in Dec. 2023 was £3.67 Mil.

Tissue Regenix Group's quarterly Ending Cash Position declined from Dec. 2022 (£4.88 Mil) to Jun. 2023 (£3.22 Mil) but then increased from Jun. 2023 (£3.22 Mil) to Dec. 2023 (£3.67 Mil).

Tissue Regenix Group's annual Ending Cash Position declined from Dec. 2021 (£5.80 Mil) to Dec. 2022 (£4.88 Mil) and declined from Dec. 2022 (£4.88 Mil) to Dec. 2023 (£3.67 Mil).

Tissue Regenix Group Ending Cash Position Historical Data

The historical data trend for Tissue Regenix Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Ending Cash Position Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2.38

9.65

5.80

4.88

3.67

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															5.80	5.01	4.88	3.22	3.67

Tissue Regenix Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Tissue Regenix Group's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.699	+	-1.025
	=	3.67

Tissue Regenix Group's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.21	+	0.464
	=	3.67

Tissue Regenix Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.